Current CA-125 thresholds may miss ovarian cancer in racially diverse patients, delaying treatment initiation and contributing to health disparities. Original CA-125 studies were conducted on ...

Tumor marker levels were measured prior to treatment. Data regarding clinical characteristics and overall survival were collected. RESULTS: Median overall survival of all patients was 15.97 months.

Black and American Indian patients are less likely to have elevated CA-125 levels compared with White patients. HealthDay News — Black and American Indian patients are less likely to have ...

However, tumor marker tests aren’t the only tools they’ll use in cancer care. Other testing techniques will help provide a more comprehensive look at your type of cancer. Regular cells may ...

Table 2. Preoperative serum levels of hCG, CA 19-9, CA 125, and CEA according to organ- confined and locally advanced bladder cancer. In assessing patient OS according to each tumor marker, the ...

However, scientists are studying the use of CA 125 tumor marker tests to help diagnose pancreatic cancer. Other types of cancer may also cause a person to have high CA 125 levels. Other names for ...

In fact, CA 125 is increased in 80% of advanced epithelial ovarian ... which is rarely associated with increased levels of tumor markers [10]. Ovarian fibroma is a benign tumor, which accounts for ...

This blood test measures the amount of a protein called cancer antigen 125 (CA-125). CA-125 is a tumor marker found in high levels in about 50% of people with early-stage ovarian cancers.

"The aim of this retrospective study was to provide additional evidence for the clinical use of conventional serum tumor markers CEA, CA19-9, and CA-125 in NSCLC management," said the researchers.

otenet.gr Rheumatoid factors (RFs) are autoantibodies directed against the Fc portion of IgG. Tumour markers (eg, CA-125, CA-19-9) are tumour-expressed proteins that are usually measured in the serum ...